Allergy Therapeutics plc HHU.F Stock
Allergy Therapeutics plc Price Chart
Allergy Therapeutics plc HHU.F Financial and Trading Overview
Allergy Therapeutics plc stock price | 0.03 EUR |
Previous Close | 0.05 EUR |
Open | 0.05 EUR |
Bid | 0 EUR x N/A |
Ask | 0 EUR x N/A |
Day's Range | 0.05 - 0.05 EUR |
52 Week Range | 0.05 - 0.23 EUR |
Volume | 20K EUR |
Avg. Volume | 0 EUR |
Market Cap | 48.21M EUR |
Beta (5Y Monthly) | 0.950191 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.07 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
HHU.F Valuation Measures
Enterprise Value | 20.61M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.66248554 |
Price/Book (mrq) | 0.7916667 |
Enterprise Value/Revenue | 0.283 |
Enterprise Value/EBITDA | -2.511 |
Trading Information
Allergy Therapeutics plc Stock Price History
Beta (5Y Monthly) | 0.950191 |
52-Week Change | -78.98% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.23 EUR |
52 Week Low | 0.05 EUR |
50-Day Moving Average | 0.05 EUR |
200-Day Moving Average | 0.1 EUR |
HHU.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 679.11M |
Float | 95.45M |
Short Ratio | N/A |
% Held by Insiders | 123.30% |
% Held by Institutions | 6.23% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2022 |
Most Recent Quarter (mrq) | June 30, 2022 |
Next Fiscal Year End | June 30, 2023 |
Profitability
Profit Margin | -18.93% |
Operating Margin (ttm) | -17.0030% |
Gross Margin | 68.03% |
EBITDA Margin | -11.27% |
Management Effectiveness
Return on Assets (ttm) | -9.56% |
Return on Equity (ttm) | -31.69% |
Income Statement
Revenue (ttm) | 72.77M EUR |
Revenue Per Share (ttm) | 0.11 EUR |
Quarterly Revenue Growth (yoy) | -20.59% |
Gross Profit (ttm) | 49.51M EUR |
EBITDA | -8207000 EUR |
Net Income Avi to Common (ttm) | -13776000 EUR |
Diluted EPS (ttm) | -0.02 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 20.52M EUR |
Total Cash Per Share (mrq) | 0.03 EUR |
Total Debt (mrq) | 10.53M EUR |
Total Debt/Equity (mrq) | 27.42 EUR |
Current Ratio (mrq) | 2.381 |
Book Value Per Share (mrq) | 0.06 |
Cash Flow Statement
Operating Cash Flow (ttm) | -14372000 EUR |
Levered Free Cash Flow (ttm) | -11695250 EUR |
Profile of Allergy Therapeutics plc
Country | Germany |
State | N/A |
City | Worthing |
Address | Dominion Way |
ZIP | BN14 8SA |
Phone | 44 1903 844 700 |
Website | https://www.allergytherapeutics.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 600 |
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Acarovac Plus, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
Q&A For Allergy Therapeutics plc Stock
What is a current HHU.F stock price?
Allergy Therapeutics plc HHU.F stock price today per share is 0.03 EUR.
How to purchase Allergy Therapeutics plc stock?
You can buy HHU.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Allergy Therapeutics plc?
The stock symbol or ticker of Allergy Therapeutics plc is HHU.F.
Which industry does the Allergy Therapeutics plc company belong to?
The Allergy Therapeutics plc industry is Drug Manufacturers-Specialty & Generic.
How many shares does Allergy Therapeutics plc have in circulation?
The max supply of Allergy Therapeutics plc shares is 5.68B.
What is Allergy Therapeutics plc Price to Earnings Ratio (PE Ratio)?
Allergy Therapeutics plc PE Ratio is now.
What was Allergy Therapeutics plc earnings per share over the trailing 12 months (TTM)?
Allergy Therapeutics plc EPS is -0.07 EUR over the trailing 12 months.
Which sector does the Allergy Therapeutics plc company belong to?
The Allergy Therapeutics plc sector is Healthcare.